Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

VTGNVistagen Therapeutics, Inc.

Nasdaq · CIK 0001411685
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end0331
XBRL facts488

Identity from submissions API

NameVistagen Therapeutics, Inc.
CIK0001411685
TickersVTGN
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN205093315
LEI—
Fiscal year end0331
State of incorporationNV NV
Phone650-577-3600
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Excaliber Enterprises, Ltd. (2007-09-11T04:00:00.000Z → 2011-06-08T04:00:00.000Z)
Business address
343 ALLERTON AVENUE
SOUTH SAN FRANCISCO
CA
94080
CA
Mailing address
343 ALLERTON AVENUE
SOUTH SAN FRANCISCO
CA
94080
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

913 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000921895-26-003193 005-86249 261561580 34 25175
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001831942-26-000051 005-86249 261560894 34 15483
2026-11-13 10-Q 10-Q 0001628280-26-073833 001-37761 261552600 34 5740949 1 1
2026-11-13 8-K 8-K 2.02,9.01 0001628280-26-073824 001-37761 261552498 34 252589 1 1
2026-11-09 8-K 8-K 8.01,9.01 0001628280-26-071910 001-37761 261534003 34 213896 1 1
2026-10-30 8-K 8-K 2.05,8.01 0001628280-26-068627 001-37761 261509121 34 140391 1 1
2026-10-09 8-K 8-K 5.02,9.01 0001628280-26-065559 001-37761 261453696 34 395633 1 1
2026-09-25 8-K 8-K 7.01,9.01 0001628280-26-063510 001-37761 261406422 34 8591528 1 1
2026-09-24 8-K 8-K 8.01,9.01 0001628280-26-063316 001-37761 261402139 34 163482 1 1
2026-09-22 8-K 8-K 8.01,9.01 0001628280-26-063046 001-37761 261397102 34 188877 1 1
2026-09-11 8-K 8-K 5.07,9.01 0001628280-26-061445 001-37761 261372392 34 152989 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000947871-26-000804 005-86249 261284043 34 16578
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-352371 005-86249 261282350 34 22712
2026-08-14 10-Q 10-Q 0001628280-26-057116 001-37761 261281693 34 5219496 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001831942-26-000032 005-86249 261281122 34 15828
2026-08-14 8-K 8-K 2.02,9.01 0001628280-26-056953 001-37761 261276472 34 241275 1 1
2026-08-06 8-K 8-K 7.01,8.01,9.01 0001628280-26-054341 001-37761 261249336 34 204561 1 1
2026-08-05 8-K 8-K 3.01 0001628280-26-053304 001-37761 261243306 34 138654 1 1
2026-07-31 DEFA14A DEFA14A 0001628280-26-051406 001-37761 261228654 34 1187187
2026-07-31 DEF 14A DEF 14A 0001628280-26-051404 001-37761 261228641 34 5429858 1 1
2026-07-31 4 xslF345X06/form4-07312026_120720.xml 0001911501-26-000006 5964
2026-07-31 3 xslF345X06/form3-07312026_120713.xml 0001911501-26-000004 15524
2026-07-31 8-K 8-K 5.02,7.01,9.01 0001628280-26-051251 001-37761 261225600 34 250463 1 1
2026-07-02 4 xslF345X06/form4-07022026_080703.xml 0001924908-26-000007 5290
2026-07-02 4 xslF345X06/form4-07022026_080720.xml 0001794362-26-000004 5187
2026-07-02 4 xslF345X06/form4-07022026_080729.xml 0001412071-26-000006 6132
2026-06-30 8-K 8-K 7.01,8.01,9.01 0001628280-26-046143 001-37761 261138098 34 1503191 1 1
2026-06-17 8-K 8-K 5.02 0001628280-26-043989 001-37761 261099451 34 134765 1 1
2026-06-15 10-K 10-K 0001628280-26-043271 001-37761 261091565 34 8260026 1 1
2026-06-15 8-K 8-K 2.02,9.01 0001628280-26-043232 001-37761 261091347 34 241114 1 1
2026-06-09 8-K 8-K 8.01,9.01 0001628280-26-041962 001-37761 261076999 34 175935 1 1
2026-05-19 4 xslF345X06/form4-05192026_080513.xml 0002132062-26-000004 6010
2026-05-19 3 xslF345X06/form3-05192026_080546.xml 0002132062-26-000003 15593
2026-05-19 8-K 8-K 5.02,7.01,9.01 0001628280-26-036492 001-37761 26999296 34 248438 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-226886 005-86249 26988253 34 21701
2026-05-12 8-K 8-K 8.01,9.01 0001628280-26-033883 001-37761 26965905 34 189406 1 1
2026-05-08 8-K 8-K 8.01,9.01 0001628280-26-032935 001-37761 26958850 34 178118 1 1
2026-04-28 8-K 8-K 8.01,9.01 0001628280-26-027930 001-37761 26907915 34 217026 1 1
2026-04-13 8-K 8-K 5.02 0001628280-26-024943 001-37761 26858622 34 137643 1 1
2026-04-09 4 PRIMARY DOCUMENT 0001794362-26-000002 5909
2026-04-09 4 PRIMARY DOCUMENT 0001412071-26-000004 13758
2026-04-09 4 PRIMARY DOCUMENT 0001998663-26-000006 13783
2026-04-09 4 PRIMARY DOCUMENT 0002069951-26-000004 11792
2026-04-09 4 PRIMARY DOCUMENT 0001924908-26-000005 13763
2026-04-02 8-K 8-K 3.01 0001628280-26-023176 001-37761 26833779 34 138036 1 1
2026-03-18 8-K 8-K 5.02 0001628280-26-019455 001-37761 26769969 34 133717 1 1
2026-03-16 8-K 8-K 7.01,9.01 0001628280-26-018163 001-37761 26756789 34 8586879 1 1
2026-03-11 8-K 8-K 8.01 0001628280-26-016652 001-37761 26741512 34 139319 1 1
2026-02-20 8-K 8-K 5.02 0001628280-26-010035 001-37761 26656872 34 134461 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000947871-26-000193 005-86249 26644365 34 15365
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001831942-26-000008 005-86249 26642000 34 16030
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-001115 005-86249 26641564 34 12516
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-26-000068 005-86249 26638831 34 12158
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-015994 005-86249 26637496 34 17177
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-015351 005-86249 26634444 34 11059
2026-02-12 10-Q 10-Q 0001628280-26-007718 001-37761 26626998 34 5108994 1 1
2026-02-12 8-K 8-K 2.02,9.01 0001628280-26-007715 001-37761 26626938 34 256158 1 1
2026-02-06 8-K 8-K 3.01 0001628280-26-006078 001-37761 26607757 34 137953 1 1
2026-01-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-26-000313 005-86249 26582666 34 7236
2026-01-09 8-K 8-K 7.01,9.01 0001628280-26-001690 001-37761 26524068 34 7833627 1 1
2026-01-05 4 PRIMARY DOCUMENT 0001998663-26-000002 4911
2025-12-22 8-K 8-K 8.01 0001628280-25-058594 001-37761 251593581 34 135093 1 1
2025-12-04 4 xslF345X05/form4-12042025_111200.xml 0001794362-25-000005 5892
2025-12-04 3 xslF345X02/form3-12042025_111242.xml 0001794362-25-000004 13910
2025-12-03 8-K 8-K 5.02,7.01,9.01 0001628280-25-055083 001-37761 251547077 34 299674 1 1
2025-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000947871-25-001019 005-86249 251488575 34 15306
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-112649 005-86249 251487388 34 11536
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001814554-25-000180 005-86249 251485042 34 15778
2025-11-13 10-Q 10-Q 0001628280-25-052079 001-37761 251479190 34 5113180 1 1
2025-11-13 8-K 8-K 2.02,9.01 0001628280-25-052077 001-37761 251479177 34 253877 1 1
2025-11-04 4 xslF345X05/form4-11042025_091145.xml 0001531178-25-000007 5849
2025-11-04 3 xslF345X02/form3-11042025_091130.xml 0001531178-25-000005 14638
2025-11-04 8-K 8-K 7.01,9.01 0001628280-25-048827 001-37761 251449111 34 179982 1 1
2025-10-31 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-25-000334 005-86249 251439138 34 6377
2025-10-29 8-K 8-K 5.02,7.01,9.01 0001628280-25-047188 001-37761 251431170 34 255039 1 1
2025-09-15 8-K 8-K 5.02,5.07,9.01 0001411685-25-000081 001-37761 251314867 34 161884 1 1
2025-09-11 4 PRIMARY DOCUMENT 0001411685-25-000078 5479
2025-09-11 4 PRIMARY DOCUMENT 0001411685-25-000077 5532
2025-09-11 4 PRIMARY DOCUMENT 0001411685-25-000076 5546
2025-09-11 4 PRIMARY DOCUMENT 0001411685-25-000075 5527
2025-09-11 4 PRIMARY DOCUMENT 0001411685-25-000074 5499
2025-09-08 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000254 005-86249 251299380 34 10730
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-003534 005-86249 251220952 34 15684
2025-08-07 10-Q 10-Q 0001411685-25-000064 001-37761 251195096 34 4774888 1 1
2025-08-07 8-K 8-K 2.02,7.01,9.01 0001411685-25-000062 001-37761 251195083 34 8723014 1 1
2025-07-28 DEFA14A DEFA14A 0001411685-25-000054 001-37761 251156651 34 1194128
2025-07-28 DEF 14A DEF 14A 0001411685-25-000052 001-37761 251156610 34 5889699 1 1
2025-07-01 4 xslF345X05/form4-07012025_090735.xml 0001415889-25-018759 5103
2025-07-01 4 xslF345X05/form4-07012025_090738.xml 0001415889-25-018755 5093
2025-07-01 4 xslF345X05/form4-07012025_090741.xml 0001415889-25-018751 5095
2025-07-01 4 xslF345X05/form4-07012025_090724.xml 0001415889-25-018748 5795
2025-06-25 4 xslF345X05/form4-06252025_090633.xml 0001415889-25-018206 6001
2025-06-25 3 xslF345X02/form3-06252025_090650.xml 0001415889-25-018205 14371
2025-06-25 4 xslF345X05/form4-06252025_050607.xml 0001415889-25-018203 5896
2025-06-25 4 xslF345X05/form4-06252025_050605.xml 0001415889-25-018202 5904
2025-06-25 4 xslF345X05/form4-06252025_050603.xml 0001415889-25-018201 5894
2025-06-25 4 xslF345X05/form4-06252025_050601.xml 0001415889-25-018200 5889
2025-06-25 8-K 8-K 5.02,9.01 0001411685-25-000048 001-37761 251074289 34 255372 1 1
2025-06-17 8-K 8-K 2.02,8.01,9.01 0001411685-25-000046 001-37761 251053940 34 344789 1 1
2025-06-17 424B5 424B5 0001411685-25-000044 333-277041 251053920 33 479177
2025-06-17 10-K 10-K 0001411685-25-000041 001-37761 251053827 34 19169250 1 1
2025-06-02 8-K 8-K 7.01,9.01 0001411685-25-000028 001-37761 251015561 34 8666193 1 1
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-002406 005-86249 25954695 34 15544
2025-03-06 8-K 8-K 8.01,9.01 0001411685-25-000023 001-37761 25716019 34 5049677 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-001209 005-86249 25630035 34 15565
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-25-000500 005-86249 25629524 34 27490
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-013829 005-86249 25625996 34 17440
2025-02-13 10-Q 10-Q 0001411685-25-000019 001-37761 25621761 34 5071207 1 1
2025-02-13 8-K 8-K 2.02,7.01,9.01 0001411685-25-000017 001-37761 25621082 34 8818497 1 1
2025-02-05 8-K 8-K 8.01,9.01 0001411685-25-000011 001-37761 25594244 34 192192 1 1
2025-01-14 8-K 8-K 8.01,9.01 0001411685-25-000007 001-37761 25530216 34 187171 1 1
2025-01-13 4 xslF345X05/form4-01132025_100154.xml 0001415889-25-001402 5111
2025-01-13 4 xslF345X05/form4-01132025_100126.xml 0001415889-25-001396 5103
2025-01-13 8-K 8-K 8.01,9.01 0001411685-25-000004 001-37761 25527157 34 180438 1 1
2024-12-06 8-K 8-K 7.01,9.01 0001411685-24-000059 001-37761 241532957 34 8371025 1 1
2024-11-14 SC 13G/A greatpoint-vtgn093024a2.htm 0001172661-24-005308 005-86249 241464109 34 115287
2024-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-24-119178 005-86249 241463808 34 11515
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-118974 005-86249 241462738 34 137284
2024-11-07 8-K 8-K 2.02,9.01 0001411685-24-000051 001-37761 241436519 34 266204 1 1
2024-11-07 10-Q 10-Q 0001411685-24-000048 001-37761 241436426 34 4897030 1 1
2024-09-23 8-K 8-K 8.01 0001411685-24-000042 001-37761 241314719 34 315126 1 1
2024-09-10 4 xslF345X05/form4-09102024_050911.xml 0001415889-24-023149 5894
2024-09-10 4 xslF345X05/form4-09102024_050909.xml 0001415889-24-023148 5853
2024-09-10 4 xslF345X05/form4-09102024_050907.xml 0001415889-24-023147 5902
2024-09-10 4 xslF345X05/form4-09102024_050905.xml 0001415889-24-023146 5874
2024-09-10 4 xslF345X05/form4-09102024_050901.xml 0001415889-24-023144 5907
2024-09-10 4 xslF345X05/form4-09102024_050903.xml 0001415889-24-023145 5921
2024-08-28 8-K FORM 8-K 5.07 0001437749-24-027943 001-37761 241255459 34 169985 1 1
2024-08-13 8-K 8-K 2.02,9.01 0001411685-24-000039 001-37761 241202545 34 249689 1 1
2024-08-13 10-Q 10-Q 0001411685-24-000037 001-37761 241202507 34 4679082 1 1
2024-07-17 DEFA14A DEFA14A 0001411685-24-000030 001-37761 241120696 34 424252
2024-07-17 DEF 14A DEF 14A 0001411685-24-000028 001-37761 241120686 34 2703277 1 1
2024-07-12 8-K FORM 8-K 4.01,9.01 0001437749-24-022667 001-37761 241114764 34 304346 1 1
2024-07-10 8-K FORM 8-K 8.01,9.01 0001437749-24-022484 001-37761 241110289 34 184444 1 1
2024-07-02 4 xslF345X05/form4-07022024_100701.xml 0001415889-24-019028 5015
2024-07-02 4 xslF345X05/form4-07022024_100748.xml 0001415889-24-019024 5007
2024-07-02 4 xslF345X05/form4-07022024_100750.xml 0001415889-24-019022 5016
2024-07-02 4 xslF345X05/form4-07022024_100738.xml 0001415889-24-019020 5729
2024-06-28 8-K FORM 8-K 8.01,9.01 0001437749-24-021626 001-37761 241087089 34 177848 1 1
2024-06-26 4 xslF345X05/form4-06272024_010639.xml 0001415889-24-018279 5918
2024-06-26 4 xslF345X05/form4-06272024_010654.xml 0001415889-24-018278 5927
2024-06-26 4 xslF345X05/form4-06272024_010602.xml 0001415889-24-018277 5919
2024-06-26 4 xslF345X05/form4-06272024_010600.xml 0001415889-24-018276 5927
2024-06-17 S-8 FORM S-8 0001437749-24-020407 333-280246 241046365 33 148725
2024-06-11 8-K 8-K 2.02,9.01 0001411685-24-000023 001-37761 241036163 34 254388 1 1
2024-06-11 10-K 10-K 0001411685-24-000022 001-37761 241036153 34 7502780 1 1
2024-05-31 8-K FORM 8-K 5.07 0001437749-24-018902 001-37761 241009746 34 164706 1 1
2024-05-24 8-K FORM 8-K 8.01,9.01 0001437749-24-018214 001-37761 24980028 34 177457 1 1
2024-04-26 8-K FORM 8-K 8.01,9.01 0001437749-24-013283 001-37761 24878140 34 188782 1 1
2024-04-16 DEF 14A FORM DEF 14A 0001437749-24-012129 001-37761 24846027 34 1370581
2024-04-05 PRE 14A FORM PRE 14A 0001437749-24-011246 001-37761 24827573 34 756599
2024-04-01 8-K FORM 8-K 8.01,9.01 0001437749-24-010427 001-37761 24811134 34 173415 1 1
2024-03-06 4 xslF345X05/form4-03062024_060318.xml 0001415889-24-007099 11027
2024-03-06 4 xslF345X05/form4-03062024_060314.xml 0001415889-24-007098 10966
2024-03-06 4 xslF345X05/form4-03062024_060311.xml 0001415889-24-007097 11056
2024-03-06 4 xslF345X05/form4-03062024_060307.xml 0001415889-24-007096 11023
2024-03-06 4 xslF345X05/form4-03062024_060304.xml 0001415889-24-007095 10997
2024-03-06 4 xslF345X05/form4-03062024_060301.xml 0001415889-24-007094 11005
2024-02-29 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-02-29 16:00:00 9999999995-24-000580 333-277041 24706699 33 1952
2024-02-27 CORRESP filename1.htm 0001437749-24-005770 12350
2024-02-16 UPLOAD filename1.pdf 0000000000-24-001884 333-277041 40528
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-024115 005-86249 24641178 34 138751
2024-02-14 SC 13G SC 13G 0001104659-24-023896 005-86249 24639805 34 57654
2024-02-14 SC 13G/A greatpoint-vtgn123123a1.htm 0001172661-24-001528 005-86249 24639457 34 119801
2024-02-14 SC 13G/A VISTAGEN THERAPEUTICS, INC. 0000902664-24-001585 005-86249 24632726 34 64012
2024-02-13 SC 13G SCHEDULE 13G 0001104659-24-022258 005-86249 24629998 34 13220
2024-02-13 S-3 FORM S-3 0001437749-24-003930 333-277041 24627022 33 1221196
2024-02-13 8-K FORM 8-K 2.02,9.01 0001437749-24-003924 001-37761 24626660 34 304883 1 1
2024-02-13 10-Q FORM 10-Q 0001437749-24-003916 001-37761 24626409 34 3781622 1 1
2024-02-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001952142-24-000002 005-86249 24621860 34 280644
2024-01-09 8-K FORM 8-K 7.01,9.01 0001437749-24-000902 001-37761 24521383 34 12241360 1 1
2024-01-03 4 xslF345X05/form4-01032024_100124.xml 0001415889-24-000350 10360
2024-01-03 4 xslF345X05/form4-01032024_100142.xml 0001415889-24-000344 11028
2024-01-03 8-K FORM 8-K 8.01,9.01 0001437749-24-000419 001-37761 24508022 34 185062 1 1
2023-11-09 10-Q FORM 10-Q 0001437749-23-031293 001-37761 231393360 34 3635454 1 1
2023-11-09 8-K FORM 8-K 2.02,9.01 0001437749-23-031291 001-37761 231393320 34 314588 1 1
2023-11-07 8-K/A FORM 8-K/A 8.01,9.01 0001437749-23-030460 001-37761 231381324 34 158952 1 1
2023-11-06 8-K FORM 8-K 8.01,9.01 0001437749-23-030402 001-37761 231380323 34 154307 1 1
2023-11-03 3 xslF345X02/form3-11042023_121106.xml 0001415889-23-014790 13826
2023-10-26 8-K FORM 8-K 5.02,9.01 0001437749-23-029096 001-37761 231350308 34 224251 1 1
2023-10-16 SC 13G SC 13G 0001193125-23-256922 005-86249 231327700 34 114182
2023-10-16 SC 13G SCHEDULE 13G 0000921895-23-002347 005-86249 231327677 34 295638
2023-10-16 SC 13G SC 13G 0001104659-23-109357 005-86249 231327351 34 134033
2023-10-12 SC 13G greatpoint-vtgn100223.htm 0001172661-23-003393 005-86249 231322761 34 120393
2023-10-06 4 xslF345X05/ownership.xml 0001493152-23-036497 14977
2023-10-06 SC 13G/A formsc13ga.htm 0001493152-23-036493 005-86249 231314246 34 94973
2023-10-05 SC 13G VISTAGEN THERAPEUTICS, INC. 0000902664-23-005016 005-86249 231311923 34 71937
2023-10-04 8-K FORM 8-K 1.01,7.01,8.01,9.01 0001437749-23-027662 001-37761 231307956 34 7120219 1 1
2023-10-03 424B5 FORM 424B5 0001437749-23-027529 333-254299 231304566 33 609915
2023-10-02 8-K FORM 8-K 8.01,9.01 0001437749-23-027327 001-37761 231297701 34 156113 1 1
2023-09-29 8-K FORM 8-K 5.07,9.01 0001437749-23-027180 001-37761 231296064 34 182851 1 1
2023-09-13 8-K FORM 8-K 8.01,9.01 0001437749-23-025721 001-37761 231251424 34 187606 1 1
2023-09-08 8-K FORM 8-K 1.01,7.01,8.01,9.01 0001437749-23-025509 001-37761 231246242 34 5738846 1 1
2023-08-23 4 xslF345X05/form4-08232023_050842.xml 0001415889-23-012532 5926
2023-08-23 3 xslF345X02/form3-08232023_050825.xml 0001415889-23-012531 9077
2023-08-22 8-K FORM 8-K 5.02,9.01 0001437749-23-024370 001-37761 231191032 34 173317 1 1
2023-08-10 10-Q FORM 10-Q 0001437749-23-023127 001-37761 231160544 34 5390071 1 1
2023-08-10 8-K FORM 8-K 2.02,9.01 0001437749-23-023114 001-37761 231160350 34 1132190 1 1
2023-08-09 SC 13G formsc13g.htm 0001493152-23-027355 005-86249 231155348 34 95174
2023-08-09 4 xslF345X05/ownership.xml 0001493152-23-027352 6464
2023-08-09 3 xslF345X02/ownership.xml 0001493152-23-027342 4987
2023-08-08 424B5 FORM 424B5 0001437749-23-022393 333-254299 231149402 33 39713
2023-08-07 8-K FORM 8-K 7.01,9.01 0001437749-23-022216 001-37761 231145769 34 194486 1 1
2023-07-28 DEFA14A FORM DEFA14A 0001437749-23-021050 001-37761 231123835 34 511664
2023-07-28 DEF 14A FORM DEF 14A 0001437749-23-021049 001-37761 231123829 34 1232768
2023-07-18 8-K FORM 8-K 8.01,9.01 0001437749-23-020080 001-37761 231092964 34 181246 1 1
2023-07-13 8-K FORM 8-K 8.01,9.01 0001437749-23-019883 001-37761 231087109 34 176724 1 1
2023-07-07 SC 13G/A us92840h2022_070723.txt 0001306550-23-009518 005-86249 231077202 34 12318
2023-07-07 8-K FORM 8-K 5.02,9.01 0001437749-23-019610 001-37761 231077132 34 156035 1 1
2023-07-05 4 xslF345X04/form4-07052023_040705.xml 0001415889-23-010721 5654
2023-07-05 4 xslF345X04/form4-07052023_040703.xml 0001415889-23-010720 4932
2023-07-05 4 xslF345X04/form4-07052023_040701.xml 0001415889-23-010719 4888
2023-06-30 424B5 FORM 424B5 0001437749-23-019024 333-254299 231061616 33 40490
2023-06-28 10-K FORM 10-K 0001437749-23-018793 001-37761 231053123 34 13593939 1 1
2023-06-28 8-K FORM 8-K 2.02,9.01 0001437749-23-018765 001-37761 231052576 34 291901 1 1
2023-06-23 8-K FORM 8-K 8.01,9.01 0001437749-23-018171 001-37761 231034925 34 175976 1 1
2023-06-21 8-K FORM 8-K 8.01,9.01 0001437749-23-018003 001-37761 231030461 34 187456 1 1
2023-06-13 8-K FORM 8-K 8.01,9.01 0001437749-23-017300 001-37761 231012293 34 176076 1 1
2023-06-07 8-K FORM 8-K 8.01,9.01 0001437749-23-016888 001-37761 23999426 34 182174 1 1
2023-06-06 8-K FORM 8-K 3.03,5.03,7.01,9.01 0001437749-23-016689 001-37761 23995058 34 200780 1 1
2023-06-01 8-K FORM 8-K 8.01,9.01 0001437749-23-016377 001-37761 23985472 34 189564 1 1
2023-04-27 8-K FORM 8-K 7.01,9.01 0001437749-23-011374 001-37761 23857365 34 10761828 1 1
2023-04-19 8-K FORM 8-K 8.01,9.01 0001437749-23-010647 001-37761 23830524 34 183914 1 1
2023-04-06 8-K FORM 8-K 8.01,9.01 0001437749-23-009679 001-37761 23806582 34 176268 1 1
2023-03-30 8-K FORM 8-K 8.01,9.01 0001437749-23-008628 001-37761 23780878 34 195132 1 1
2023-03-23 8-K FORM 8-K 8.01,9.01 0001437749-23-007585 001-37761 23754676 34 190153 1 1
2023-03-21 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-03-21 16:00:00 9999999995-23-000623 333-270232 23751167 33 1903
2023-03-17 CORRESP filename1.htm 0001437749-23-007070 17604
2023-03-17 S-3/A FORM S-3/A 0001437749-23-007069 333-270232 23743010 33 439885
2023-03-09 UPLOAD filename1.pdf 0000000000-23-002301 40409
2023-03-08 8-K FORM 8-K 8.01,9.01 0001437749-23-005818 001-37761 23717285 34 177525 1 1
2023-03-07 8-K FORM 8-K 3.01,9.01 0001437749-23-005679 001-37761 23713185 34 155994 1 1
2023-03-02 S-3 FORM S-3 0001437749-23-005232 333-270232 23699629 33 448905
2023-03-02 8-K FORM 8-K 8.01,9.01 0001437749-23-005131 001-37761 23695817 34 173980 1 1
2023-02-21 D xslFormDX01/primary_doc.xml 06b 0001437749-23-003840 021-473834 23644494 33 12428
2023-02-14 SC 13G/A AMENDMENT NO. 2 0000947871-23-000193 005-86249 23631738 34 58152
2023-02-14 SC 13G/A formsc13ga.htm 0001493152-23-004860 005-86249 23628885 34 87815
2023-02-14 SC 13G/A vistagen13ga3.htm 0000935836-23-000252 005-86249 23628001 34 80207
2023-02-07 8-K FORM 8-K 2.02,9.01 0001851734-23-000037 001-37761 23595444 34 315370 1 1
2023-02-07 10-Q FORM 10-Q 0001851734-23-000035 001-37761 23595299 34 7740086 1 1
2023-02-02 8-K FORM 8-K 3.02,8.01,9.01 0001851734-23-000029 001-37761 23578970 34 174499 1 1
2023-02-01 SC 13G/A us92840h2022_020123.txt 0001306550-23-006401 005-86249 23577617 34 13167
2023-02-01 SC 13G/A vist22a11.htm 0000038777-23-000039 005-86249 23575992 34 185854
2023-01-25 8-K FORM 8-K 8.01,9.01 0001851734-23-000021 001-37761 23549169 34 182867 1 1
2023-01-12 8-K FORM 8-K 8.01,9.01 0001851734-23-000003 001-37761 23524807 34 177835 1 1
2023-01-03 4 xslF345X03/form4-01032023_090100.xml 0001415889-23-000043 4764
2023-01-03 4 xslF345X03/form4-01032023_090116.xml 0001415889-23-000041 5517
2022-12-21 8-K FORM 8-K 1.01,7.01,9.01 0001851734-22-000740 001-37761 221476613 34 923189 1 1
2022-12-06 8-K FORM 8-K 8.01,9.01 0001851734-22-000719 001-37761 221447971 34 176032 1 1
2022-12-01 8-K FORM 8-K 8.01,9.01 0001851734-22-000709 001-37761 221436918 34 177751 1 1
2022-11-23 8-K FORM 8-K 7.01,9.01 0001851734-22-000699 001-37761 221411993 34 3271859 1 1
2022-11-22 8-K FORM 8-K 5.02,8.01,9.01 0001851734-22-000697 001-37761 221407170 34 187085 1 1
2022-11-10 8-K FORM 8-K 2.02,9.01 0001851734-22-000663 001-37761 221377977 34 305062 1 1
2022-11-10 10-Q FORM 10-Q 0001851734-22-000662 001-37761 221377570 34 7759810 1 1
2022-10-28 8-K FORM 8-K 5.07 0001851734-22-000643 001-37761 221342619 34 163116 1 1
2022-10-19 8-K FORM 8-K 5.07,7.01,9.01 0001851734-22-000626 001-37761 221318977 34 215869 1 1
2022-10-06 DEFA14A FORM DEFA14A 0001851734-22-000594 001-37761 221298762 34 37299
2022-10-06 8-K FORM 8-K 8.01,9.01 0001851734-22-000591 001-37761 221298735 34 191391 1 1
2022-09-08 8-K FORM 8-K 7.01,8.01,9.01 0001851734-22-000549 001-37761 221232582 34 179298 1 1
2022-09-07 8-K FORM 8-K 3.01 0001851734-22-000545 001-37761 221231235 34 157208 1 1
2022-08-31 DEFA14A FORM DEFA14A 0001851734-22-000518 001-37761 221218525 34 580427
2022-08-31 DEF 14A FORM DEF 14A 0001851734-22-000517 001-37761 221218520 34 1326074
2022-08-31 8-K FORM 8-K 5.03,9.01 0001851734-22-000516 001-37761 221218508 34 169998 1 1
2022-08-22 4 xslF345X03/form4-08222022_020840.xml 0001415889-22-008937 8312
2022-08-22 PRE 14A FORM PRE 14A 0001851734-22-000475 001-37761 221181839 34 898045
2022-08-19 4 xslF345X03/form4-08192022_030801.xml 0001415889-22-008894 5167
2022-08-18 4 xslF345X03/form4-08182022_120836.xml 0001415889-22-008814 5891
2022-08-17 8-K FORM 8-K 7.01,9.01 0001851734-22-000465 001-37761 221171493 34 227462 1 1
2022-08-12 SC 13D/A GROWTH EQUITY OPPORTUNITIES 17, LLC -- VISTAGEN--SCH 13D/A(#2E) 0001072613-22-000504 005-86249 221161219 34 107783
2022-08-11 8-K FORM 8-K 2.02,9.01 0001851734-22-000435 001-37761 221156261 34 285017 1 1
2022-08-11 10-Q FORM 10-Q 0001851734-22-000432 001-37761 221156121 34 5808388 1 1
2022-07-22 8-K FORM 8-K 8.01,9.01 0001851734-22-000390 001-37761 221098513 34 187932 1 1
2022-07-15 4 xslF345X03/form4-07152022_040701.xml 0001415889-22-007686 4985
2022-07-15 4 xslF345X03/form4-07152022_040717.xml 0001415889-22-007688 5541
2022-07-15 4 xslF345X03/form4-07152022_040709.xml 0001415889-22-007687 4780
2022-07-14 4 FORM 4 SUBMISSION 0001209191-22-042152 20882
2022-07-08 3 FORM 3 SUBMISSION 0001209191-22-041617 19144
2022-07-08 SC 13G/A SC 13G/A 0001104659-22-078364 005-86249 221074422 34 269734
2022-06-23 8-K FORM 8-K 2.02,9.01 0001851734-22-000350 001-37761 221035860 34 297333 1 1
2022-06-23 10-K FORM 10-K 0001851734-22-000349 001-37761 221035748 34 12931795 1 1
2022-06-22 8-K FORM 8-K 5.02,8.01,9.01 0001851734-22-000341 001-37761 221032646 34 194096 1 1
2022-06-09 8-K FORM 8-K 7.01,9.01 0001851734-22-000316 001-37761 221004857 34 6618439 1 1
2022-05-16 4 xslF345X03/form4-05162022_100519.xml 0001415889-22-004988 7617
2022-05-06 8-K FORM 8-K 8.01,9.01 0001437749-22-011170 001-37761 22898278 34 193242 1 1
2022-05-03 8-K FORM 8-K 5.02,9.01 0001437749-22-010697 001-37761 22888232 34 183874 1 1
2022-05-03 4 xslF345X03/form4-05032022_020513.xml 0001415889-22-004542 5532
2022-05-03 3 xslF345X02/form3-05032022_020539.xml 0001415889-22-004541 19606
2022-04-22 8-K FORM 8-K 8.01,9.01 0001437749-22-009449 001-37761 22842545 34 188543 1 1
2022-04-14 SC 13G VISTAGEN_13GAPR42022 0000905718-22-000607 005-86249 22827812 34 65399
2022-04-13 8-K FORM 8-K 8.01,9.01 0001437749-22-008855 001-37761 22824767 34 216313 1 1
2022-03-03 4 xslF345X03/form4-03032022_010304.xml 0001415889-22-002300 5667
2022-03-03 4 xslF345X03/form4-03032022_010306.xml 0001415889-22-002297 5659
2022-03-03 4 xslF345X03/form4-03032022_010313.xml 0001415889-22-002296 5671
2022-03-03 4 xslF345X03/form4-03032022_010311.xml 0001415889-22-002294 5697
2022-03-03 4 xslF345X03/form4-03032022_010333.xml 0001415889-22-002292 5423
2022-03-03 4 xslF345X03/form4-03032022_010341.xml 0001415889-22-002291 5491
2022-03-03 4 xslF345X03/form4-03032022_010344.xml 0001415889-22-002290 5464
2022-03-03 4 xslF345X03/form4-03032022_010355.xml 0001415889-22-002289 5477
2022-03-03 4 xslF345X03/form4-03032022_010302.xml 0001415889-22-002287 5472
2022-02-15 SC 13G/A vistagen13ga2.htm 0000935836-22-000196 005-86249 22638687 34 81565
2022-02-14 SC 13G/A SC 13G/A 0001104659-22-022889 005-86249 22632429 34 197034
2022-02-11 SC 13G/A AMENDMENT NO. 1 0000947871-22-000218 005-86249 22622308 34 60711
2022-02-10 8-K FORM 8-K 2.02,9.01 0001437749-22-003012 001-37761 22614171 34 314251 1 1
2022-02-10 10-Q FORM 10-Q 0001437749-22-003009 001-37761 22614122 34 8035766 1 1
2022-02-04 SC 13G us92840h2022_020422.txt 0000834237-22-007125 005-86249 22593362 34 13201
2022-02-04 SC 13G vist21in.htm 0000038777-22-000034 005-86249 22591795 34 202562
2022-01-12 4 xslF345X03/form4-01122022_020137.xml 0001415889-22-000507 6900
2022-01-03 4 xslF345X03/form4-01032022_010104.xml 0001415889-22-000046 4784
2022-01-03 4 xslF345X03/form4-01032022_010120.xml 0001415889-22-000041 4791
2022-01-03 4 xslF345X03/form4-01032022_010112.xml 0001415889-22-000038 5537
2022-01-03 4 xslF345X03/form4-01032022_010137.xml 0001415889-22-000034 5543
2021-11-16 CT ORDER filename1.pdf 20211116,20211116 9999999997-21-005725 001-37761 211414132 34 160503
2021-11-10 8-K FORM 8-K 2.02,9.01 0001437749-21-026182 001-37761 211397424 34 316150 1 1
2021-11-10 10-Q FORM 10-Q 0001437749-21-026161 001-37761 211396871 34 7279634 1 1
2021-10-15 8-K FORM 8K 8.01,9.01 0001654954-21-011105 001-37761 211324644 34 169611 1 1
2021-10-05 8-K PRIMARY DOCUMENT 8.01,9.01 0001654954-21-010839 001-37761 211307798 34 165492 1 1
2021-09-24 S-8 REGISTRATION STATEMENT 0001654954-21-010401 333-259779 211277432 33 134921
2021-09-17 8-K PRIMARY DOCUMENT 5.07,9.01 0001654954-21-010193 001-37761 211260967 34 180909 1 1
2021-09-13 8-K CURRENT REPORT 8.01,9.01 0001654954-21-009957 001-37761 211248519 34 181364 1 1
2021-09-08 4 xslF345X03/form4-09082021_030907.xml 0001415889-21-004287 4575
2021-09-03 4 xslF345X03/form4-09032021_010953.xml 0001415889-21-004226 6587
2021-08-18 4 xslF345X03/form4-08182021_030825.xml 0001415889-21-004002 5555
2021-08-12 8-K PRIMARY DOCUMENT 2.02,9.01 0001654954-21-008859 001-37761 211168370 34 4630166 1 1
2021-08-12 10-Q QUARTERLY REPORT 0001654954-21-008845 001-37761 211167772 34 4800843 1 1
2021-07-29 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001654954-21-008336 001-37761 211128565 34 306055
2021-07-29 DEF 14A DEFINITIVE PROXY STATEMENT 0001654954-21-008334 001-37761 211128539 34 1400074
2021-07-22 4 xslF345X03/form4-07222021_010706.xml 0001415889-21-003674 5571
2021-07-22 3 xslF345X02/form3-07222021_010736.xml 0001415889-21-003672 9128
2021-07-22 8-K CURRENT REPORT 5.02,9.01 0001654954-21-008125 001-37761 211107674 34 117067
2021-07-21 8-K CURRENT REPORT 4.01,9.01 0001654954-21-008103 001-37761 211104560 34 38046
2021-07-08 8-K CURRENT REPORT 5.02,9.01 0001654954-21-007757 001-37761 211080339 34 112506
2021-07-07 4 xslF345X03/form4-07072021_010752.xml 0001415889-21-003544 5557
2021-07-07 3 xslF345X02/form3-07072021_010702.xml 0001415889-21-003542 8898
2021-07-02 4 xslF345X03/form4-07022021_040710.xml 0001415889-21-003388 4802
2021-07-02 4 xslF345X03/form4-07022021_040729.xml 0001415889-21-003391 18344
2021-07-02 4 xslF345X03/form4-07022021_040701.xml 0001415889-21-003387 5562
2021-07-02 4 xslF345X03/form4-07022021_040716.xml 0001415889-21-003389 4828
2021-06-29 8-K CURRENT REPORT 2.02,9.01 0001654954-21-007382 001-37761 211058207 34 214177
2021-06-29 10-K ANNUAL REPORT 0001654954-21-007380 001-37761 211058177 34 7630852 1
2021-06-17 8-K CURRENT REPORT 8.01,9.01 0001654954-21-006979 001-37761 211022975 34 56336
2021-06-15 8-K CURRENT REPORT 7.01,9.01 0001654954-21-006883 001-37761 211016274 34 4159688
2021-05-27 8-K CURRENT REPORT 8.01,9.01 0001654954-21-006329 001-37761 21970676 34 52289
2021-05-14 8-K CURRENT REPORT 1.01,9.01 0001654954-21-005701 001-37761 21924633 34 343771
2021-05-14 424B5 PROSPECTUS SUPPLEMENT 0001654954-21-005699 333-254299 21924550 33 529672
2021-05-04 4 xslF345X03/form4-05042021_010553.xml 0001415889-21-002243 5614
2021-05-04 8-K CURRENT REPORT 5.02,9.01 0001654954-21-005102 001-37761 21889126 34 47592
2021-04-29 SC 13D/A GROWTH EQUITY OPPORTUNITIES 17, LLC -- VISTAGEN--SCH 13D/A(#1) 0001072613-21-000386 005-86249 21867696 34 523159
2021-04-27 4 xslF345X03/form4-04272021_010440.xml 0001415889-21-002139 7444
2021-04-27 4 xslF345X03/form4-04272021_010425.xml 0001415889-21-002138 5617
2021-04-27 3 xslF345X02/form3-04272021_010435.xml 0001415889-21-002137 8890
2021-04-27 8-K CURRENT REPORT 5.02,9.01 0001654954-21-004680 001-37761 21858905 34 108208
2021-04-26 8-K CURRENT REPORT 8.01 0001654954-21-004643 001-37761 21854985 34 26024
2021-03-26 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-03-26 10:00:00 9999999995-21-001167 333-254299 21779314 33 1799
2021-03-23 CORRESP filename1.htm 0001654954-21-003132 17638
2021-03-22 4 xslF345X03/form4-03222021_040356.xml 0001415889-21-001609 6746
2021-03-22 4 xslF345X03/form4-03222021_040300.xml 0001415889-21-001607 7420
2021-03-22 UPLOAD filename1.pdf 0000000000-21-003429 40298
2021-03-22 SC 13G formsc13g.htm 0001493152-21-006482 005-86249 21759784 34 164309
2021-03-15 S-3 REGISTRATION STATEMENT 0001654954-21-002812 333-254299 21742234 33 534404
2021-03-05 8-K CURRENT REPORT 5.03,5.07,9.01 0001654954-21-002420 001-37761 21719073 34 123078
2021-02-16 SC 13G SCHEDULE 13G 0001104659-21-023994 005-86249 21638464 34 230319
2021-02-16 SC 13G formsc13g.htm 0001493152-21-003772 005-86249 21631925 34 128437
2021-02-12 SC 13G SCHEDULE 13G 0000947871-21-000187 005-86249 21629441 34 72299
2021-02-12 8-K CURRENT REPORT 2.02,9.01 0001654954-21-001603 001-37761 21627181 34 231708
2021-02-11 10-Q 10-Q 0001654954-21-001538 001-37761 21620305 34 5101589 1
2021-02-02 4 xslF345X03/form4-02022021_020242.xml 0001415889-21-000508 5474
2021-02-02 3 xslF345X02/form3-02022021_020210.xml 0001415889-21-000506 43014
2021-02-02 8-K form8k-02022021_020247.htm 5.02 0001415889-21-000504 001-37761 21582605 34 16822
2021-01-22 SC 13G/A SC 13G/A 0001019056-21-000055 005-86249 21547187 34 126789
2021-01-14 DEF 14A DEFINITIVE PROXY STATEMENT 0001654954-21-000472 001-37761 21529221 34 477871
2021-01-06 8-K CURRENT REPORT 8.01,9.01 0001654954-21-000194 001-37761 21510506 34 56133
2021-01-04 4 xslF345X03/form4-01042021_010143.xml 0001415889-21-000022 5543
2021-01-04 4 xslF345X03/form4-01042021_010131.xml 0001415889-21-000020 8030
2021-01-04 4 xslF345X03/form4-01042021_010114.xml 0001415889-21-000018 7278
2021-01-04 4 xslF345X03/form4-01042021_010147.xml 0001415889-21-000016 7270
2021-01-04 4 xslF345X03/form4-01042021_010129.xml 0001415889-21-000014 5564
2021-01-04 4 xslF345X03/form4-01042021_010146.xml 0001415889-21-000012 5618
2021-01-04 4 xslF345X03/form4-01042021_010119.xml 0001415889-21-000009 5612
2021-01-04 4 xslF345X03/form4-01042021_010136.xml 0001415889-21-000007 7295
2021-01-04 4 xslF345X03/form4-01042021_010145.xml 0001415889-21-000005 5523
2021-01-04 SC 13D GROWTH EQUITY OPPORTUNITIES 17, LLC -- VISTAGEN--SCH 13D 0001072613-21-000001 005-86249 21500018 34 520915
2020-12-31 PRE 14A PRELIMINARY PROXY STATEMENT 0001654954-20-014095 001-37761 201429484 34 260344
2020-12-22 8-K FORM 8-K 1.01,3.03,5.03,7.01,8.01,9.01 0001654954-20-013839 001-37761 201408168 34 550509
2020-12-21 424B5 PROSPECTUS SUPPLEMENT 0001654954-20-013762 333-234025 201402098 33 736660
2020-12-18 FWP FWP 0001654954-20-013719 333-234025 201397969 34 29018
2020-12-17 424B5 PROSPECTUS SUPPLEMENT 0001654954-20-013701 333-234025 201397021 33 726586
2020-12-01 8-K CURRENT REPORT 8.01,9.01 0001654954-20-013104 001-37761 201361095 34 55196
2020-11-16 8-K CURRENT REPORT 2.02,7.01,9.01 0001654954-20-012380 001-37761 201313196 34 264326
2020-11-12 10-Q QUARTERLY REPORT 0001654954-20-012266 001-37761 201307337 34 4995109 1
2020-10-13 8-K CURRENT REPORT 3.01,7.01,9.01 0001654954-20-011086 001-37761 201237048 34 5042481
2020-09-18 SC 13G SC 13G 0001019056-20-000505 005-86249 201184502 34 125356
2020-09-18 8-K CURRENT REPORT 5.07,7.01,9.01 0001654954-20-010220 001-37761 201182839 34 123141
2020-08-24 4 xslF345X03/form4-08242020_010800.xml 0001415889-20-002181 5849
2020-08-14 8-K CURRENT REPORT 2.02,7.01,9.01 0001654954-20-009204 001-37761 201106726 34 4655531
2020-08-13 10-Q QUARTERLY REPORT 0001654954-20-009069 001-37761 201099692 34 4376267 1
2020-08-06 8-K CURRENT REPORT 1.01,8.01,9.01 0001654954-20-008543 001-37761 201079563 34 388755
2020-08-04 424B5 PROSPECTUS SUPPLEMENT 0001654954-20-008335 333-234025 201070724 33 625973
2020-07-31 424B5 PROSPECTUS SUPPLEMENT 0001654954-20-008269 333-234025 201066158 33 629531
2020-07-27 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001654954-20-008044 001-37761 201050950 34 264723
2020-07-27 DEF 14A DEF 14A 0001654954-20-008042 001-37761 201050943 34 1073938

Latest XBRL company facts

One latest value per concept from companyfacts (488 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 46.19M 2026-11-10 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
dei EntityPublicFloat Entity Public Float USD 137.70M 2025-09-30 2026 FY 10-K 2026-06-15 0001628280-26-043271
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 326,777 2025-04-01 2026-03-31 DEF 14A 2026-07-31 0001628280-26-051404
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 700,672 2025-04-01 2026-03-31 DEF 14A 2026-07-31 0001628280-26-051404
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 132,446 2025-04-01 2026-03-31 DEF 14A 2026-07-31 0001628280-26-051404
ecd PeoTotalCompAmt PeoTotalCompAmt USD 1.21M 2025-04-01 2026-03-31 DEF 14A 2026-07-31 0001628280-26-051404
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 1.66 2025-04-01 2026-03-31 DEF 14A 2026-07-31 0001628280-26-051404
invest InvestmentWarrantsExercisePrice Investment Warrants, Exercise Price USD 7 2016-01-01 2016-02-12 2016 Q3 10-Q 2016-02-16 0001415889-16-004781
us-gaap AcceleratedShareRepurchasesInitialPricePaidPerShare Accelerated Share Repurchases, Initial Price Paid Per Share USD/shares 21.16 2020-12-01 2020-12-31 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent Accounts Payable and Accrued Liabilities USD 15,000 2020-06-30 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap AccountsPayableAndAccruedLiabilitiesNoncurrent Accounts Payable and Accrued Liabilities, Noncurrent USD 3.01M 2015-03-31 2016 Q3 10-Q 2016-02-16 0001415889-16-004781
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.08M 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap AccountsPayableInterestBearingNoncurrent Accounts Payable, Interest-bearing, Noncurrent USD 0 2016-12-31 2016 Q3 10-Q 2017-02-13 0001654954-17-001004
us-gaap AccruedBonusesCurrentAndNoncurrent Accrued Bonuses USD 105,000 2017-12-31 2018 Q3 10-Q 2018-02-12 0001654954-18-001360
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 0 2019-12-31 2020 Q3 10-Q 2020-02-13 0001654954-20-001517
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 6.64M 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 750,000 2020-06-30 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 493,000 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap AccruedRoyaltiesCurrentAndNoncurrent Accrued Royalties USD 25,000 2013-03-31 2014 FY 10-K 2014-06-25 0001415889-14-001957
us-gaap AccruedVacationCurrent Accrued Vacation, Current USD 0 2016-12-31 2016 Q3 10-Q 2017-02-13 0001654954-17-001004
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 1.07M 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -11,000 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 520.01M 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap AdjustmentOfWarrantsGrantedForServices Adjustment of Warrants Granted for Services USD 119,700 2018-04-01 2019-03-31 2019 FY 10-K 2019-06-25 0001654954-19-007632
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD 23.00M 2020-04-01 2021-03-31 2021 FY 10-K 2021-06-29 0001654954-21-007380
us-gaap AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings USD 945,100 2021-04-01 2022-03-31 2023 FY 10-K 2023-06-28 0001437749-23-018793
us-gaap AdjustmentsToAdditionalPaidInCapitalMarkToMarket Adjustments to Additional Paid in Capital, Fair Value USD 98,400 2014-04-01 2015-03-31 2016 FY 10-K 2016-06-24 0001415889-16-006331
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD -29,400 2020-04-01 2020-06-30 2021 Q3 10-Q 2021-02-11 0001654954-21-001538
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 907,000 2026-07-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 252,000 2013-04-01 2013-12-31 2015 Q3 10-Q 2015-02-17 0001415889-15-000568
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 29,400 2020-04-01 2020-06-30 2022 Q3 10-Q 2022-02-10 0001437749-22-003009
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 300,000 2019-10-01 2019-12-31 2021 Q3 10-Q 2021-02-11 0001654954-21-001538
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 1.90M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 0 2016-04-01 2016-12-31 2016 Q3 10-Q 2017-02-13 0001654954-17-001004
us-gaap AmortizationOfDeferredLeasingFees Amortization of Deferred Leasing Fees USD 146,300 2017-04-01 2018-03-31 2018 FY 10-K 2018-06-26 0001654954-18-006990
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 0 2016-04-01 2017-03-31 2017 FY 10-K 2017-06-29 0001654954-17-005976
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 16.49M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap Assets Assets USD 23.42M 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap AssetsCurrent Assets, Current USD 22.29M 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 20.03M 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 0 2024-03-31 2025 FY 10-K 2025-06-17 0001411685-25-000041
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 9.14M 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued Business Acquisition, Equity Interest Issued or Issuable, Number of Shares shares 341,823 2011-05-10 2015-05-11 2015 Q3 10-Q 2015-02-17 0001415889-15-000568
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap CapitalizedContractCostNet Capitalized Contract Cost, Net USD 268,000 2023-06-30 2024 Q1 10-Q 2023-08-10 0001437749-23-023127
us-gaap CapitalizedContractCostNetCurrent Capitalized Contract Cost, Net, Current USD 67,100 2023-06-30 2024 Q1 10-Q 2023-08-10 0001437749-23-023127
us-gaap CapitalizedContractCostNetNoncurrent Capitalized Contract Cost, Net, Noncurrent USD 200,900 2023-06-30 2024 Q1 10-Q 2023-08-10 0001437749-23-023127
us-gaap CapitalLeasedAssetsGross Capital Leased Assets, Gross USD 14,700 2021-06-30 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap CapitalLeaseObligations Capital Lease Obligations USD 4,500 2014-03-31 2015 FY 10-K 2015-06-29 0001415889-15-002221
us-gaap CapitalLeaseObligationsCurrent Capital Lease Obligations, Current USD 3,000 2021-03-31 2021 FY 10-K 2021-06-29 0001654954-21-007380
us-gaap CapitalLeaseObligationsIncurred Lease Obligation Incurred USD 139,700 1998-11-26 2014-03-31 2014 FY 10-K 2014-06-25 0001415889-14-001957
us-gaap CapitalLeaseObligationsNoncurrent Capital Lease Obligations, Noncurrent USD 0 2021-03-31 2021 FY 10-K 2021-06-29 0001654954-21-007380
us-gaap CapitalLeasesBalanceSheetAssetsByMajorClassNet Capital Leases, Balance Sheet, Assets by Major Class, Net USD 1,600 2021-06-30 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap CapitalLeasesFutureMinimumPaymentsDue Capital Leases, Future Minimum Payments Due USD 2,500 2014-03-31 2015 FY 10-K 2015-06-29 0001415889-15-002221
us-gaap CapitalLeasesFutureMinimumPaymentsDueCurrent Capital Leases, Future Minimum Payments Due, Next Twelve Months USD 3,200 2021-03-31 2021 FY 10-K 2021-06-29 0001654954-21-007380
us-gaap CapitalLeasesFutureMinimumPaymentsDueInFiveYears Capital Leases, Future Minimum Payments Due in Five Years USD 3,300 2017-03-31 2017 FY 10-K 2017-06-29 0001654954-17-005976
us-gaap CapitalLeasesFutureMinimumPaymentsDueInFourYears Capital Leases, Future Minimum Payments Due in Four Years USD 3,300 2018-03-31 2018 FY 10-K 2018-06-26 0001654954-18-006990
us-gaap CapitalLeasesFutureMinimumPaymentsDueInThreeYears Capital Leases, Future Minimum Payments Due in Three Years USD 3,300 2019-03-31 2019 FY 10-K 2019-06-25 0001654954-19-007632
us-gaap CapitalLeasesFutureMinimumPaymentsDueInTwoYears Capital Leases, Future Minimum Payments Due in Two Years USD 3,000 2020-03-31 2020 FY 10-K 2020-06-29 0001654954-20-007107
us-gaap CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments Capital Leases, Future Minimum Payments, Interest Included in Payments USD 200 2021-03-31 2021 FY 10-K 2021-06-29 0001654954-21-007380
us-gaap CapitalLeasesFutureMinimumPaymentsNetMinimumPayments1 Capital Leases, Future Minimum Payments, Net Minimum Payments USD 3,200 2021-03-31 2021 FY 10-K 2021-06-29 0001654954-21-007380
us-gaap CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments USD 3,000 2021-03-31 2021 FY 10-K 2021-06-29 0001654954-21-007380
us-gaap CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation Capital Leases, Lessee Balance Sheet, Assets by Major Class, Accumulated Depreciation USD 13,100 2021-06-30 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap CapitalLeasesLesseeBalanceSheetAssetsByMajorClassOtherPropertyPlantAndEquipment Capital Leases, Lessee Balance Sheet, Assets by Major Class, Other Property, Plant, and Equipment, Gross USD 19,000 2013-03-31 2015 FY 10-K 2015-06-29 0001415889-15-002221
us-gaap CapitalLeasesLesseeBalanceSheetAssetsByMajorClassOtherPropertyPlantAndEquipmentNet Capital Leases, Lessee Balance Sheet, Assets by Major Class, Other Property, Plant, and Equipment, Net USD 4,500 2014-03-31 2015 FY 10-K 2015-06-29 0001415889-15-002221
us-gaap CapitalLeasesLesseeBalanceSheetAssetsByMajorClassPropertyPlantAndEquipmentOtherAccumulatedDepreciation Capital Leases, Lessee Balance Sheet, Assets by Major Class, Property, Plant, and Equipment Other, Accumulated Depreciation USD -2,500 2014-03-31 2015 FY 10-K 2015-06-29 0001415889-15-002221
us-gaap CapitalLeasesNetInvestmentInDirectFinancingLeasesInitialDirectCosts Capital Leases, Net Investment in Direct Financing Leases, Initial Direct Costs USD 25,000 2013-12-31 2013 Q3 10-Q 2014-02-14 0001415889-14-000587
us-gaap Cash Cash USD 13,200 2014-12-31 2015 Q3 10-Q 2015-02-17 0001415889-15-000568
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 10.89M 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 119.17M 2024-03-31 2025 Q2 10-Q 2024-11-07 0001411685-24-000048
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -5.33M 2021-04-01 2021-06-30 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 20.00M 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 10.89M 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -19.90M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap ChemicalsRevenue Chemicals Revenue (Deprecated 2016-01-31) USD 187,200 2012-04-01 2012-06-30 2012 Q1 10-Q 2012-08-14 0001415889-12-001223
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) USD/shares_unit 1.5 2012-12-31 2012 Q3 10-Q 2013-02-14 0001415889-13-000263
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 8.877 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 9.28M 2022-03-31 2022 FY 10-K 2022-06-23 0001851734-22-000349
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 11.27M 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap CommitmentsAndContingencies Commitments and Contingencies USD 0 2011-12-31 2011 Q3 10-Q 2012-02-14 0001415889-12-000216
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 67.73M 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap CommonStockOtherSharesOutstanding Common Stock, Other Shares, Outstanding shares 2.71M 2021-06-30 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 325.00M 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 45.60M 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 19.64M 2012-06-30 2012 Q1 10-Q 2012-08-14 0001415889-12-001223
us-gaap CommonStockValue Common Stock, Value, Issued USD 46,000 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -23.78M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 96,000 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 0 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 716 2016-01-01 2016-02-12 2016 Q3 10-Q 2016-02-16 0001415889-16-004781
us-gaap ConvertibleDebt Convertible Debt USD 439,900 2020-09-30 2021 Q2 10-Q 2020-11-12 0001654954-20-012266
us-gaap ConvertibleDebtCurrent Convertible Debt, Current USD 352,600 2020-09-30 2021 Q2 10-Q 2020-11-12 0001654954-20-012266
us-gaap ConvertibleDebtNoncurrent Convertible Debt, Noncurrent USD 87,300 2020-09-30 2021 Q2 10-Q 2020-11-12 0001654954-20-012266
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 0 2016-12-31 2016 Q3 10-Q 2017-02-13 0001654954-17-001004
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 438,900 2020-09-30 2021 Q2 10-Q 2020-11-12 0001654954-20-012266
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 35,800 2016-12-31 2016 Q3 10-Q 2017-02-13 0001654954-17-001004
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 750,000 2014-03-31 2015 FY 10-K 2015-06-29 0001415889-15-002221
us-gaap CostsIncurredOilAndGasPropertyAcquisitionExplorationAndDevelopmentActivities Costs Incurred, Oil and Gas Property Acquisition, Exploration, and Development Activities USD 172.00M 2020-08-01 2020-08-31 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 0 2016-04-01 2017-03-31 2017 FY 10-K 2017-06-29 0001654954-17-005976
us-gaap DebtConversionConvertedInstrumentRate Debt Conversion, Converted Instrument, Rate pure 0.905 2012-04-01 2013-03-31 2012 FY 10-K 2013-07-18 0001415889-13-001409
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 13,500 2016-01-01 2016-02-12 2016 Q3 10-Q 2016-02-16 0001415889-16-004781
us-gaap DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1 Debt Conversion, Converted Instrument, Warrants or Options Issued shares 39,714 2016-04-01 2016-12-31 2016 Q3 10-Q 2017-02-13 0001654954-17-001004
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD 4.50M 2015-04-01 2015-06-23 2015 FY 10-K 2015-06-29 0001415889-15-002221
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 15.88M 2016-03-31 2017 FY 10-K 2017-06-29 0001654954-17-005976
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 1.30M 2015-03-31 2016 FY 10-K 2016-06-24 0001415889-16-006331
us-gaap DebtInstrumentInterestRateDuringPeriod Debt Instrument, Interest Rate During Period pure 0.1 2015-01-01 2015-02-13 2015 Q3 10-Q 2015-02-17 0001415889-15-000568
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.1 2014-12-31 2015 Q3 10-Q 2015-02-17 0001415889-15-000568
us-gaap DebtInstrumentPeriodicPaymentPrincipal Debt Instrument, Periodic Payment, Principal USD 12,500 2011-12-01 2012-06-30 2012 Q1 10-Q 2012-08-14 0001415889-12-001223
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD -54,500 2015-03-31 2016 FY 10-K 2016-06-24 0001415889-16-006331
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 130,000 2024-03-31 2024 FY 10-K 2024-06-11 0001411685-24-000022
us-gaap DeferredCostsCurrent Deferred Costs, Current USD 74,000 2024-03-31 2024 FY 10-K 2024-06-11 0001411685-24-000022
us-gaap DeferredCostsCurrentAndNoncurrent Deferred Costs USD 334,300 2021-06-30 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 0 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 224,700 2021-06-30 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap DeferredPolicyAcquisitionCostsAdditions Deferred Policy Acquisition Cost, Capitalization USD 0 2021-04-01 2021-06-30 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap DeferredPolicyAcquisitionCostsDisposition Deferred Policy Acquisition Costs, Disposition USD 33,300 2021-04-01 2021-06-30 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap DeferredRentCredit Deferred Rent Credit USD 0 2019-12-31 2020 Q3 10-Q 2020-02-13 0001654954-20-001517
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 0 2020-03-31 2020 FY 10-K 2020-06-29 0001654954-20-007107
us-gaap DeferredRevenue Deferred Revenue USD 3.03M 2023-03-31 2023 FY 10-K 2023-06-28 0001437749-23-018793
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 714,300 2023-03-31 2023 FY 10-K 2023-06-28 0001437749-23-018793
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 2.31M 2023-03-31 2023 FY 10-K 2023-06-28 0001437749-23-018793
us-gaap DeferredRevenueRefundPayments1 Deferred Revenue, Refund Payments USD 354,100 2021-04-01 2021-06-30 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap DeferredRevenueRevenueRecognized1 Deferred Revenue, Revenue Recognized USD 0 2021-04-01 2021-06-30 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 0 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 93.37M 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 70.86M 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 39.18M 2021-03-31 2021 FY 10-K 2021-06-29 0001654954-21-007380
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration USD 52.90M 2021-03-31 2021 FY 10-K 2021-06-29 0001654954-21-007380
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 64.56M 2021-03-31 2021 FY 10-K 2021-06-29 0001654954-21-007380
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration USD 86.28M 2021-03-31 2021 FY 10-K 2021-06-29 0001654954-21-007380
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 38,000 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 2.42M 2021-03-31 2021 FY 10-K 2021-06-29 0001654954-21-007380
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsOther Deferred Tax Assets, Tax Credit Carryforwards, Other USD 105,300 2021-03-31 2021 FY 10-K 2021-06-29 0001654954-21-007380
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 7.73M 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 2.83M 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 138,000 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 93.37M 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 0 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 0 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 101,000 2024-03-31 2024 FY 10-K 2024-06-11 0001411685-24-000022
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 129,500 2022-04-01 2023-03-31 2023 FY 10-K 2023-06-28 0001437749-23-018793
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 102,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap Dividends Dividends USD 0 2021-04-01 2022-03-31 2023 FY 10-K 2023-06-28 0001437749-23-018793
us-gaap DividendsPreferredStock Dividends, Preferred Stock USD 1.04M 2020-04-01 2020-12-31 2021 Q3 10-Q 2021-02-11 0001654954-21-001538
us-gaap DividendsPreferredStockCash Dividends, Preferred Stock, Cash USD 353,600 2020-10-01 2020-12-31 2021 Q3 10-Q 2021-02-11 0001654954-21-001538
us-gaap DividendsPreferredStockPaidinkind Dividends, Preferred Stock, Paid-in-kind USD 6,200 2016-01-01 2016-02-12 2016 Q3 10-Q 2016-02-16 0001415889-16-004781
us-gaap DividendsPreferredStockStock Dividends, Preferred Stock, Stock USD 23.00M 2020-04-01 2021-03-31 2021 FY 10-K 2021-06-29 0001654954-21-007380
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 1.51M 2015-03-31 2016 Q3 10-Q 2016-02-16 0001415889-16-004781
us-gaap DueToRelatedPartiesNoncurrent Due to Related Parties, Noncurrent USD 1.12M 2014-12-31 2015 Q3 10-Q 2015-02-17 0001415889-15-000568
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.54 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.16 2021-04-01 2021-12-31 2022 Q3 10-Q 2022-02-10 0001437749-22-003009
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.54 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.185 2023-04-01 2024-03-31 2024 FY 10-K 2024-06-11 0001411685-24-000022
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.006 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure 0.043 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-17 0001411685-25-000041
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure -0.014 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations USD 0 2016-04-01 2016-06-30 2016 Q1 10-Q 2016-08-12 0001415889-16-006799
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 323,000 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 3.85M 2021-03-31 2021 FY 10-K 2021-06-29 0001654954-21-007380
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 3.90M 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares Employee Stock Ownership Plan (ESOP), Number of Committed-to-be-Released Shares shares 248,129 2014-03-31 2015 FY 10-K 2015-06-29 0001415889-15-002221
us-gaap ExtinguishmentOfDebtAmount Extinguishment of Debt, Amount USD 26.70M 2015-04-01 2016-03-31 2016 Q3 10-Q 2017-02-13 0001654954-17-001004
us-gaap ExtinguishmentOfDebtGainLossIncomeTax Extinguishment of Debt, Gain (Loss), Income Tax USD 132,900 2014-04-01 2014-12-31 2015 Q3 10-Q 2015-02-17 0001415889-15-000568
us-gaap ExtinguishmentOfDebtGainLossNetOfTax Extinguishment of Debt, Gain (Loss), Net of Tax USD 26.70M 2015-03-01 2015-09-30 2016 FY 10-K 2016-06-24 0001415889-16-006331
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 0 2023-04-01 2024-03-31 2024 FY 10-K 2024-06-11 0001411685-24-000022
us-gaap FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings Fair Value, Assets and Liabilities Measured on Recurring Basis, Gain (Loss) Included in Earnings USD 1.89M 2015-04-01 2015-12-31 2016 Q3 10-Q 2016-02-16 0001415889-16-004781
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2017-04-01 2017-09-30 2018 Q3 10-Q 2018-02-12 0001654954-18-001360
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 0.923 2017-04-01 2017-09-30 2018 Q3 10-Q 2018-02-12 0001654954-18-001360
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.02 2017-04-01 2017-09-30 2018 Q3 10-Q 2018-02-12 0001654954-18-001360
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net USD -4.90M 2015-04-01 2015-12-31 2016 Q3 10-Q 2016-02-16 0001415889-16-004781
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 3.01M 2015-03-31 2016 Q3 10-Q 2016-02-16 0001415889-16-004781
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 9,100 2023-03-31 2023 FY 10-K 2023-06-28 0001437749-23-018793
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 1,900 2023-12-31 2024 Q3 10-Q 2024-02-13 0001437749-24-003916
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 6,000 2023-12-31 2024 Q3 10-Q 2024-02-13 0001437749-24-003916
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 12,200 2023-03-31 2023 FY 10-K 2023-06-28 0001437749-23-018793
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 2,900 2023-03-31 2023 FY 10-K 2023-06-28 0001437749-23-018793
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 600 2023-03-31 2023 FY 10-K 2023-06-28 0001437749-23-018793
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 2,900 2023-03-31 2023 FY 10-K 2023-06-28 0001437749-23-018793
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 2,900 2023-03-31 2023 FY 10-K 2023-06-28 0001437749-23-018793
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 2,900 2023-03-31 2023 FY 10-K 2023-06-28 0001437749-23-018793
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 3,100 2023-03-31 2023 FY 10-K 2023-06-28 0001437749-23-018793
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 1,200 2023-04-01 2023-12-31 2024 Q3 10-Q 2024-02-13 0001437749-24-003916
us-gaap FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization Finance Lease, Right-of-Use Asset, before Accumulated Amortization USD 10,600 2023-03-31 2023 FY 10-K 2023-06-28 0001437749-23-018793
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 0 2026-06-30 2027 Q1 10-Q 2026-08-14 0001628280-26-057116
us-gaap ForeignCurrencyTransactionGainBeforeTax Foreign Currency Transaction Gain, before Tax USD -22,000 2014-04-01 2014-12-31 2015 Q3 10-Q 2015-02-17 0001415889-15-000568
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD 0 2016-04-01 2017-03-31 2017 FY 10-K 2017-06-29 0001654954-17-005976
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 0 2016-04-01 2016-12-31 2016 Q3 10-Q 2017-02-13 0001654954-17-001004
us-gaap GainLossOnSaleOfDerivatives Gain (Loss) on Sale of Derivatives USD 528,300 2014-04-01 2014-12-31 2015 Q3 10-Q 2015-02-17 0001415889-15-000568
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2019-04-01 2020-03-31 2021 FY 10-K 2021-06-29 0001654954-21-007380
us-gaap GainsLossesOnRecourseDebt Gains (Losses) on Recourse Debt USD 2.37M 2014-04-01 2014-12-31 2015 Q3 10-Q 2015-02-17 0001415889-15-000568
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 8.44M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -23.77M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -11.72M 2020-04-01 2020-12-31 2021 Q3 10-Q 2021-02-11 0001654954-21-001538
us-gaap IncomeTaxesPaid Income Taxes Paid USD 2,400 2014-04-01 2015-03-31 2015 FY 10-K 2015-06-29 0001415889-15-002221
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 3,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap IncomeTaxPaidForeignAfterRefundReceived IncomeTaxPaidForeignAfterRefundReceived USD 0 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 3,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 15.70M 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -14.63M 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 430,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 0 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 953,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 7,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -2.57M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 106,200 2012-04-01 2013-03-31 2014 FY 10-K 2014-06-25 0001415889-14-001957
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -1.58M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap IncreaseDecreaseInDeferredCharges Increase (Decrease) in Deferred Charges USD 0 2019-04-01 2020-03-31 2020 FY 10-K 2020-06-29 0001654954-20-007107
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -320,800 2021-04-01 2021-06-30 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap IncreaseDecreaseInDepositOtherAssets Increase (Decrease) in Deposit Assets USD -17,900 2013-04-01 2014-03-31 2015 FY 10-K 2015-06-29 0001415889-15-002221
us-gaap IncreaseDecreaseInDepositsOutstanding Increase (Decrease) in Deposits Outstanding USD 0 2022-04-01 2023-03-31 2023 FY 10-K 2023-06-28 0001437749-23-018793
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD -3.07M 2012-04-01 2013-03-31 2014 FY 10-K 2014-06-25 0001415889-14-001957
us-gaap IncreaseDecreaseInNotesPayableCurrent Increase (Decrease) in Notes Payable, Current USD 34,300 2014-04-01 2014-09-30 2014 Q2 10-Q 2014-11-19 0001415889-14-003624
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -338,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -101,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD -230,700 2020-04-01 2020-12-31 2021 Q3 10-Q 2021-02-11 0001654954-21-001538
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD -3,400 2021-04-01 2021-06-30 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 758,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap IncreaseDecreaseInReceivables Increase (Decrease) in Receivables USD -1.25M 2016-04-01 2016-12-31 2016 Q3 10-Q 2017-02-13 0001654954-17-001004
us-gaap IncrementalCommonSharesAttributableToConversionOfDebtSecurities Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities shares 18,179 2014-04-01 2014-12-31 2016 Q3 10-Q 2016-02-16 0001415889-16-004781
us-gaap IncrementalCommonSharesAttributableToConversionOfPreferredStock Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock shares 30,000 2015-04-01 2015-06-23 2015 FY 10-K 2015-06-29 0001415889-15-002221
us-gaap IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements Incremental Common Shares Attributable to Dilutive Effect of Equity Unit Purchase Agreements shares 282,850 2014-04-01 2015-03-31 2015 FY 10-K 2015-06-29 0001415889-15-002221
us-gaap InterestExpense Interest Expense USD -33,400 2019-04-01 2019-12-31 2020 Q3 10-Q 2020-02-13 0001654954-20-001517
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 1.82M 2023-04-01 2023-12-31 2024 Q3 10-Q 2024-02-13 0001437749-24-003916
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 515,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 13,300 2020-04-01 2021-03-31 2021 FY 10-K 2021-06-29 0001654954-21-007380
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap InterestPayableCurrent Interest Payable, Current USD 0 2016-12-31 2016 Q3 10-Q 2017-02-13 0001654954-17-001004
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 1,000 2020-09-30 2021 Q2 10-Q 2020-11-12 0001654954-20-012266
us-gaap InterestReceivable Interest Receivable USD 2,800 2014-03-31 2015 FY 10-K 2015-06-29 0001415889-15-002221
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 69,100 2019-04-01 2019-06-30 2020 Q1 10-Q 2019-08-13 0001654954-19-009386
us-gaap LeaseCost Lease, Cost USD 1.07M 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.085 2022-12-31 2022 Q3 10-Q 2023-02-07 0001851734-23-000035
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 1.01M 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 253,600 2022-03-31 2022 FY 10-K 2022-06-23 0001851734-22-000349
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 754,000 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 253,600 2023-06-30 2024 Q1 10-Q 2023-08-10 0001437749-23-023127
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 254,000 2024-03-31 2024 FY 10-K 2024-06-11 0001411685-24-000022
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 254,000 2025-03-31 2025 FY 10-K 2025-06-17 0001411685-25-000041
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 254,000 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 169,000 2022-12-31 2022 Q3 10-Q 2023-02-07 0001851734-23-000035
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 60,000 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap Liabilities Liabilities USD 8.43M 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 23.42M 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap LiabilitiesCurrent Liabilities, Current USD 8.43M 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap LiabilitiesFairValueAdjustment Liabilities, Fair Value Adjustment USD -105,200 2014-04-01 2015-03-31 2016 FY 10-K 2016-06-24 0001415889-16-006331
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 3.64M 2023-09-30 2024 Q2 10-Q 2023-11-09 0001437749-23-031293
us-gaap LicensesRevenue Licenses Revenue (Deprecated 2018-01-31) USD 0 2017-04-01 2018-03-31 2018 FY 10-K 2018-06-26 0001654954-18-006990
us-gaap LineOfCreditFacilityAmountOutstanding Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) USD 242,273 2011-04-29 2012 Q1 10-Q 2012-08-14 0001415889-12-001223
us-gaap LongTermDebt Long-term Debt USD 58,800 2016-03-31 2016 FY 10-K 2016-06-24 0001415889-16-006331
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD -1.51M 2015-03-31 2016 FY 10-K 2016-06-24 0001415889-16-006331
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive Long-Term Debt, Maturity, after Year Five USD 71,600 2013-03-31 2012 FY 10-K 2013-07-18 0001415889-13-001409
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months USD 2.19M 2015-03-31 2015 FY 10-K 2015-06-29 0001415889-15-002221
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 31,600 2016-03-31 2016 FY 10-K 2016-06-24 0001415889-16-006331
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour Long-term Debt, Maturities, Repayments of Principal in Rolling Year Four USD 11,300 2015-03-31 2015 FY 10-K 2015-06-29 0001415889-15-002221
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree Long-term Debt, Maturities, Repayments of Principal in Rolling Year Three USD 10,500 2015-03-31 2015 FY 10-K 2015-06-29 0001415889-15-002221
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo Long-term Debt, Maturities, Repayments of Principal in Rolling Year Two USD 9,800 2015-03-31 2015 FY 10-K 2015-06-29 0001415889-15-002221
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 93,800 2013-03-31 2014 FY 10-K 2014-06-25 0001415889-14-001957
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 93,800 2014-03-31 2015 FY 10-K 2015-06-29 0001415889-15-002221
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 11,200 2016-03-31 2016 FY 10-K 2016-06-24 0001415889-16-006331
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 10,400 2016-03-31 2016 FY 10-K 2016-06-24 0001415889-16-006331
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 0 2016-12-31 2016 Q3 10-Q 2017-02-13 0001654954-17-001004
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 87,300 2020-09-30 2021 Q2 10-Q 2020-11-12 0001654954-20-012266
us-gaap MachineryAndEquipmentGross Machinery and Equipment, Gross USD 653,600 2015-03-31 2015 FY 10-K 2015-06-29 0001415889-15-002221
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 1.26M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 16.52M 2017-04-01 2018-03-31 2018 FY 10-K 2018-06-26 0001654954-18-006990
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 5.71M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -26.87M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -9.06M 2017-04-01 2018-03-31 2018 FY 10-K 2018-06-26 0001654954-18-006990
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -23.77M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap NetIncomeLossAttributableToParentDiluted Net Income (Loss) Attributable to Parent, Diluted USD -41.99M 2015-04-01 2015-12-31 2016 Q3 10-Q 2016-02-16 0001415889-16-004781
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -59.25M 2022-04-01 2023-03-31 2023 FY 10-K 2023-06-28 0001437749-23-018793
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -51.42M 2015-04-01 2016-03-31 2016 FY 10-K 2016-06-24 0001415889-16-006331
us-gaap NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1 Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Shares Issued shares 400,000 2015-04-01 2015-06-23 2015 FY 10-K 2015-06-29 0001415889-15-002221
us-gaap NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationWarrantsIssued1 Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Warrants Issued shares 18,286 2016-01-01 2016-02-12 2016 Q3 10-Q 2016-02-16 0001415889-16-004781
us-gaap NotesAndLoansPayableCurrent Notes and Loans Payable, Current USD 98,400 2020-12-31 2021 Q3 10-Q 2021-02-11 0001654954-21-001538
us-gaap NotesIssued1 Notes Issued USD 0 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-08-14 0001628280-26-057116
us-gaap NotesPayable Notes Payable USD 96,000 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap NotesPayableCurrent Notes Payable, Current USD 0 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 1.51M 2015-03-31 2016 FY 10-K 2016-06-24 0001415889-16-006331
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap OperatingExpenses Operating Expenses USD 25.90M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -24.28M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap OperatingLeaseCost Operating Lease, Cost USD 645,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 3,500 2023-04-01 2023-06-30 2024 Q1 10-Q 2023-08-10 0001437749-23-023127
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 948,000 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 610,000 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap OperatingLeasePayments Operating Lease, Payments USD 700,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 513,000 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 288,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 2.16M 2019-12-31 2020 Q3 10-Q 2020-02-13 0001654954-20-001517
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 623,900 2019-12-31 2020 Q3 10-Q 2020-02-13 0001654954-20-001517
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 225,300 2017-03-31 2017 FY 10-K 2017-06-29 0001654954-17-005976
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 0 2019-12-31 2020 Q3 10-Q 2020-02-13 0001654954-20-001517
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 225,300 2019-12-31 2020 Q3 10-Q 2020-02-13 0001654954-20-001517
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 668,400 2019-12-31 2020 Q3 10-Q 2020-02-13 0001654954-20-001517
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 0 2019-12-31 2020 Q3 10-Q 2020-02-13 0001654954-20-001517
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 645,800 2019-12-31 2020 Q3 10-Q 2020-02-13 0001654954-20-001517
us-gaap OperatingLeasesRentExpenseMinimumRentals Operating Leases, Rent Expense, Minimum Rentals USD 45,000 2012-04-01 2013-03-31 2012 FY 10-K 2013-07-18 0001415889-13-001409
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 3,600 2021-04-01 2021-06-30 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.085 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 53,000 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 289,000 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, after Tax USD -4,000 2026-07-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -9,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap OtherExpenses Other Expenses USD 12.90M 2020-08-01 2020-08-31 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap OtherIncome Other Income USD 0 2021-04-01 2021-06-30 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 417,100 2011-03-31 2011 FY 10-K 2012-07-02 0001415889-12-000973
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 2,300 2015-04-01 2016-03-31 2016 FY 10-K 2016-06-24 0001415889-16-006331
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 7,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -1,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap OtherNotesPayableCurrent Other Notes Payable, Current USD 4.16M 2015-03-31 2016 Q3 10-Q 2016-02-16 0001415889-16-004781
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 2,100 2020-12-31 2021 Q3 10-Q 2021-02-11 0001654954-21-001538
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 44,000 2021-06-30 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap OtherSalesRevenueNet Other Revenue, Net (Deprecated 2018-01-31) USD 1.12M 1998-11-26 2014-03-31 2014 FY 10-K 2014-06-25 0001415889-14-001957
us-gaap PartnersCapitalAccountPrivatePlacementOfUnits Partners' Capital Account, Private Placement of Units USD 525,000 2012-10-01 2012-12-31 2012 Q3 10-Q 2013-02-14 0001415889-13-000263
us-gaap PaymentsForCapitalImprovements Payments for Capital Improvements USD 0 2019-04-01 2019-12-31 2020 Q3 10-Q 2020-02-13 0001654954-20-001517
us-gaap PaymentsForRestructuring Payments for Restructuring USD -9,700 2014-04-01 2014-12-31 2015 Q3 10-Q 2015-02-17 0001415889-15-000568
us-gaap PaymentsForSecuritiesPurchasedUnderAgreementsToResell Payments for Securities Purchased under Agreements to Resell USD 1.00M 2015-04-01 2015-06-23 2015 FY 10-K 2015-06-29 0001415889-15-002221
us-gaap PaymentsOfDebtExtinguishmentCosts Payment for Debt Extinguishment or Debt Prepayment Cost USD -134,900 2014-04-01 2014-12-31 2016 Q3 10-Q 2016-02-16 0001415889-16-004781
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 29,400 2020-04-01 2020-06-30 2021 Q1 10-Q 2020-08-13 0001654954-20-009069
us-gaap PaymentsOfMergerRelatedCostsFinancingActivities Payments of Merger Related Costs, Financing Activities USD 161,900 2021-04-01 2021-06-30 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 59,400 2022-04-01 2022-06-30 2022 Q1 10-Q 2022-08-11 0001851734-22-000432
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 6.56M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap PaymentsToAcquireMachineryAndEquipment Payments to Acquire Machinery and Equipment USD 0 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap PaymentsToAcquireNotesReceivable Payments to Acquire Notes Receivable USD 1.50M 2015-04-01 2015-06-23 2015 FY 10-K 2015-06-29 0001415889-15-002221
us-gaap PaymentsToAcquireProductiveAssets Payments to Acquire Productive Assets USD 0 2023-04-01 2024-03-31 2024 FY 10-K 2024-06-11 0001411685-24-000022
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 212,000 2022-04-01 2022-12-31 2022 Q3 10-Q 2023-02-07 0001851734-23-000035
us-gaap PreferredStockConvertibleDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount PreferredStockConvertibleDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount USD 0 2021-04-01 2022-03-31 2022 FY 10-K 2022-06-23 0001851734-22-000349
us-gaap PreferredStockDividendsAndOtherAdjustments Preferred Stock Dividends and Other Adjustments USD 1.04M 2020-04-01 2020-12-31 2021 Q3 10-Q 2021-02-11 0001654954-21-001538
us-gaap PreferredStockDividendsIncomeStatementImpact Preferred Stock Dividends, Income Statement Impact USD 0 2022-04-01 2023-03-31 2023 FY 10-K 2023-06-28 0001437749-23-018793
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 500,000 2015-06-30 2016 Q1 10-Q 2015-08-14 0001415889-15-002728
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 2.26M 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 547,500 2020-12-31 2021 Q3 10-Q 2021-02-11 0001654954-21-001538
us-gaap PrepaidInsurance Prepaid Insurance USD 503,000 2021-06-30 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap PrepaidRent Prepaid Rent USD 20,200 2013-09-30 2013 Q2 10-Q 2013-11-14 0001415889-13-002318
us-gaap PrepaidRoyalties Prepaid Royalties USD 0 2016-12-31 2016 Q3 10-Q 2017-02-13 0001654954-17-001004
us-gaap ProceedsFromCollectionOfNotesReceivable Proceeds from Collection of Notes Receivable USD 60,000 2014-04-01 2014-12-31 2015 Q3 10-Q 2015-02-17 0001415889-15-000568
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 100.00M 2021-04-01 2021-06-30 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 119.00M 2020-04-01 2021-03-31 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap ProceedsFromFeesReceived Proceeds from Fees Received USD 5.00M 2020-08-01 2020-08-30 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap ProceedsFromGrantors Proceeds from Grantors USD 17.60M 2018-04-01 2018-12-31 2019 Q3 10-Q 2019-02-12 0001654954-19-001372
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 1.28M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 250,000 2013-04-01 2014-03-31 2015 FY 10-K 2015-06-29 0001415889-15-002221
us-gaap ProceedsFromIssuanceOfFinancialServicesObligations Proceeds from Issuance of Financial Services Obligations USD 28.70M 1998-08-01 2015-12-31 2016 Q3 10-Q 2016-02-16 0001415889-16-004781
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 0 2021-04-01 2022-03-31 2022 FY 10-K 2022-06-23 0001851734-22-000349
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 50,000 2020-04-01 2020-04-30 2022 FY 10-K 2022-06-23 0001851734-22-000349
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 1.04M 1998-05-26 2011-12-31 2011 Q3 10-Q 2012-02-14 0001415889-12-000216
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 8,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap ProceedsFromLoans Proceeds from Loans USD 64,000 2014-04-01 2014-12-31 2015 Q3 10-Q 2015-02-17 0001415889-15-000568
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 0 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 0 2020-04-01 2020-12-31 2021 Q3 10-Q 2021-02-11 0001654954-21-001538
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 64,000 2013-04-01 2014-03-31 2015 FY 10-K 2015-06-29 0001415889-15-002221
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 12.28M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap ProceedsFromSaleOfEquitySecuritiesFvNi ProceedsFromSaleOfEquitySecuritiesFvNi USD 119.00M 2020-04-01 2021-03-31 2023 FY 10-K 2023-06-28 0001437749-23-018793
us-gaap ProceedsFromSaleOfNotesReceivable Proceeds from Sale of Notes Receivable USD 250,000 2013-04-01 2013-12-31 2015 Q3 10-Q 2015-02-17 0001415889-15-000568
us-gaap ProceedsFromSaleOfSecuritiesOperatingActivities Proceeds from Sale of Securities, Operating Activities USD 278,000 2016-04-01 2016-12-31 2016 Q3 10-Q 2017-02-13 0001654954-17-001004
us-gaap ProceedsFromSecuritiesPurchasedUnderAgreementsToResell Proceeds from Securities Purchased under Agreements to Resell USD 3.10M 2014-04-01 2015-03-31 2015 FY 10-K 2015-06-29 0001415889-15-002221
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 7,000 2025-04-01 2025-12-31 2026 Q3 10-Q 2026-02-12 0001628280-26-007718
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 74,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap ProceedsFromUnsecuredLinesOfCredit Proceeds from Unsecured Lines of Credit USD 200,000 1998-11-26 2014-03-31 2014 FY 10-K 2014-06-25 0001415889-14-001957
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 3,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap ProfessionalFees Professional Fees USD 345,000 2020-07-01 2020-09-30 2022 FY 10-K 2022-06-23 0001851734-22-000349
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -5.30M 2020-10-01 2020-12-31 2021 Q3 10-Q 2021-02-11 0001654954-21-001538
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 1.50M 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 325,000 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap ReceivablesNetCurrent Receivables, Net, Current USD 1.25M 2016-12-31 2016 Q3 10-Q 2017-02-13 0001654954-17-001004
us-gaap RedeemablePreferredStockDividends Redeemable Preferred Stock Dividends USD 0 2017-04-01 2017-12-31 2018 Q3 10-Q 2018-02-12 0001654954-18-001360
us-gaap RepaymentsOfLongTermCapitalLeaseObligations Repayments of Long-term Capital Lease Obligations USD 900 2021-04-01 2021-06-30 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 96,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 3,600 2014-04-01 2014-12-31 2015 Q3 10-Q 2015-02-17 0001415889-15-000568
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 17.46M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 7.59M 2020-04-01 2020-12-31 2021 Q3 10-Q 2021-02-11 0001654954-21-001538
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 5.60M 2021-04-01 2021-06-30 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings Restricted Stock, Shares Issued Net of Shares for Tax Withholdings shares 128,350 2015-01-01 2015-02-13 2015 Q3 10-Q 2015-02-17 0001415889-15-000568
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -501.09M 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 1.61M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap RevenueFromGrants Revenue from Grants (Deprecated 2018-01-31) USD 16.40M 1998-05-01 2016-03-31 2016 FY 10-K 2016-06-24 0001415889-16-006331
us-gaap RevenueNotFromContractWithCustomer Revenue Not from Contract with Customer USD 354,100 2021-04-01 2021-06-30 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap Revenues Revenues USD -227,000 2022-04-01 2023-03-31 2023 FY 10-K 2023-06-28 0001437749-23-018793
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 0 2023-04-01 2023-12-31 2024 Q3 10-Q 2024-02-13 0001437749-24-003916
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 1.76M 2018-04-01 2018-06-30 2019 Q1 10-Q 2018-08-14 0001654954-18-009096
us-gaap SeniorLongTermNotes Senior Notes, Noncurrent USD 296,200 2015-03-31 2016 FY 10-K 2016-06-24 0001415889-16-006331
us-gaap SeniorNotesCurrent Senior Notes, Current USD 4.15M 2015-03-31 2016 FY 10-K 2016-06-24 0001415889-16-006331
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 1.90M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 650,000 2016-04-01 2016-09-30 2016 Q2 10-Q 2016-11-14 0001415889-16-007413
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.2 2017-04-01 2017-09-30 2018 Q3 10-Q 2018-02-12 0001654954-18-001360
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 1.27 2021-03-31 2021 FY 10-K 2021-06-29 0001654954-21-007380
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2021-04-01 2021-12-31 2022 Q3 10-Q 2022-02-10 0001437749-22-003009
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.838 2020-04-01 2021-03-31 2021 FY 10-K 2021-06-29 0001654954-21-007380
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.005 2020-04-01 2021-03-31 2021 FY 10-K 2021-06-29 0001654954-21-007380
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate pure 0.993 2018-04-01 2018-09-30 2019 Q2 10-Q 2018-10-29 0001654954-18-011665
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 1.84M 2021-03-31 2021 FY 10-K 2021-06-29 0001654954-21-007380
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 2.79M 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 10.05 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 0 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 264,369 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 90,000 2015-04-01 2015-12-31 2016 Q3 10-Q 2016-02-16 0001415889-16-004781
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.03M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.51 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period shares -113,979 2011-04-01 2012-03-31 2012 FY 10-K 2013-07-18 0001415889-13-001409
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 5.22M 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease), Weighted Average Exercise Price USD/shares 7 2021-04-01 2021-06-30 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 6.22 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 0 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 5.22M 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 6.22 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 4.10M 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 0 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 10.44 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0.53 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Other Share Increase (Decrease) in Period, Weighted Average Exercise Price USD/shares 1.56 2017-04-01 2017-09-30 2018 Q3 10-Q 2018-02-12 0001654954-18-001360
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 1.32 2022-03-31 2022 FY 10-K 2022-06-23 0001851734-22-000349
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit USD/shares 11.94 2022-09-12 2023 FY 10-K 2023-06-28 0001437749-23-018793
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 44,071 2022-09-12 2023 FY 10-K 2023-06-28 0001437749-23-018793
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 19.39M 2022-03-31 2022 FY 10-K 2022-06-23 0001851734-22-000349
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price USD/shares 1.47 2022-03-31 2022 FY 10-K 2022-06-23 0001851734-22-000349
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit USD/shares 53.1 2022-09-12 2023 FY 10-K 2023-06-28 0001437749-23-018793
us-gaap SharePrice Share Price USD/shares 1.27 2018-09-30 2019 Q2 10-Q 2018-10-29 0001654954-18-011665
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 5.38 2023-10-02 2024 Q3 10-Q 2024-02-13 0001437749-24-003916
us-gaap SharesOutstanding Shares, Outstanding shares 1.63M 2019-06-30 2020 Q1 10-Q 2019-08-13 0001654954-19-009386
us-gaap ShortTermBorrowings Short-term Debt USD 105,000 2010-08-31 2012 Q1 10-Q 2012-08-14 0001415889-12-001223
us-gaap StateAndLocalIncomeTaxExpenseBenefitContinuingOperations State and Local Income Tax Expense (Benefit), Continuing Operations USD 7,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap StockGrantedDuringPeriodValueSharebasedCompensation Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture USD 13,600 2020-10-01 2020-12-31 2021 Q3 10-Q 2021-02-11 0001654954-21-001538
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 14.99M 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap StockholdersEquityBeforeTreasuryStock Stockholders' Equity before Treasury Stock USD 85.62M 2021-06-30 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.033 2023-06-06 2024 FY 10-K 2024-06-11 0001411685-24-000022
us-gaap StockIssued1 Stock Issued USD 223,500 2016-04-01 2016-12-31 2016 Q3 10-Q 2017-02-13 0001654954-17-001004
us-gaap StockIssuedDuringPeriodSharesAcquisitions Stock Issued During Period, Shares, Acquisitions shares 413,670 2022-04-01 2023-03-31 2024 FY 10-K 2024-06-11 0001411685-24-000022
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 46.00M 2021-04-01 2021-06-30 2022 FY 10-K 2022-06-23 0001851734-22-000349
us-gaap StockIssuedDuringPeriodSharesIssuedForCash Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) shares 768,500 2015-01-01 2015-02-13 2015 Q3 10-Q 2015-02-17 0001415889-15-000568
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 10,375 2016-03-01 2016-03-31 2016 FY 10-K 2016-06-24 0001415889-16-006331
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 3.58M 2023-04-01 2023-12-31 2024 Q3 10-Q 2024-02-13 0001437749-24-003916
us-gaap StockIssuedDuringPeriodSharesOther Stock Issued During Period, Shares, Other shares 46.00M 2020-12-01 2020-12-31 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensation Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture shares 200,000 2014-04-01 2014-06-30 2014 Q1 10-Q 2014-08-12 0001415889-14-002406
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 3.03M 2022-04-01 2023-03-31 2024 FY 10-K 2024-06-11 0001411685-24-000022
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 0 2021-04-01 2021-06-30 2022 Q2 10-Q 2022-11-10 0001851734-22-000662
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 0 2020-04-01 2021-03-31 2021 FY 10-K 2021-06-29 0001654954-21-007380
us-gaap StockIssuedDuringPeriodValueEmployeeBenefitPlan Stock Issued During Period, Value, Employee Benefit Plan USD 26,200 2020-04-01 2021-03-31 2021 FY 10-K 2021-06-29 0001654954-21-007380
us-gaap StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan Stock Issued During Period, Value, Employee Stock Ownership Plan USD 2.75M 2020-04-01 2020-06-30 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 74,000 2026-04-01 2026-06-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 125,000 2020-04-01 2021-03-31 2022 FY 10-K 2022-06-23 0001851734-22-000349
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 30.59M 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 124,600 2020-04-01 2021-03-31 2021 FY 10-K 2021-06-29 0001654954-21-007380
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 8,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap StockOptionPlanExpense Stock or Unit Option Plan Expense USD 15,500 2015-04-01 2015-06-30 2016 Q1 10-Q 2015-08-14 0001415889-15-002728
us-gaap TenantImprovements Tenant Improvements USD 26,900 2015-03-31 2015 FY 10-K 2015-06-29 0001415889-15-002221
us-gaap TreasuryStockCarryingBasis Treasury Stock, Carrying Basis USD 3.97M 2013-03-31 2012 FY 10-K 2013-07-18 0001415889-13-001409
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 4,522 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap TreasuryStockCommonValue Treasury Stock, Common, Value USD 3.97M 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap TreasuryStockShares Treasury Stock, Shares shares 135,665 2021-06-30 2021 Q1 10-Q 2021-08-12 0001654954-21-008845
us-gaap TreasuryStockValue Treasury Stock, Value USD 3.97M 2022-12-31 2022 Q3 10-Q 2023-02-07 0001851734-23-000035
us-gaap UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums Unamortized Loan Commitment and Origination Fees and Unamortized Discounts or Premiums USD 1.18M 2014-12-31 2015 Q3 10-Q 2015-02-17 0001415889-15-000568
us-gaap UnitsOfPartnershipInterestAmount Units of Partnership Interest, Amount shares 784,500 2014-03-31 2015 FY 10-K 2015-06-29 0001415889-15-002221
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 2.58M 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 0 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 178,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 3.65M 2023-04-01 2024-03-31 2025 FY 10-K 2025-06-17 0001411685-25-000041
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 0 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 2.92M 2020-04-01 2021-03-31 2021 FY 10-K 2021-06-29 0001654954-21-007380
us-gaap ValuationAllowancesAndReservesPeriodIncreaseDecrease SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease) USD 9.53M 2017-04-01 2018-03-31 2018 FY 10-K 2018-06-26 0001654954-18-006990
us-gaap VariableLeaseCost Variable Lease, Cost USD 421,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-15 0001628280-26-043271
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 424,100 2013-03-31 2012 FY 10-K 2013-07-18 0001415889-13-001409
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 43.71M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 195.18M 2021-04-01 2021-12-31 2022 Q3 10-Q 2022-02-10 0001437749-22-003009
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 197.98M 2021-04-01 2022-03-31 2022 FY 10-K 2022-06-23 0001851734-22-000349
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 43.71M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-13 0001628280-26-073833

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →